Globus Medical saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 63 to 73.
How To Invest In Stocks In Both Bull And Bear Markets
This unique rating tracks market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks matched up against all other stocks.
Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of their moves. See if Globus Medical can continue to rebound and hit that benchmark.
Globus Medical is not currently showing a potential entry point. See if the stock goes on to form a base that could spark a new run.
Globus Medical posted 40% earnings growth last quarter. Sales rose 7%. The next quarterly numbers are expected on or around May 8.
The company holds the No. 13 rank among its peers in the Medical-Products industry group. Pro-Dex, Penumbra and Boston Scientific are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
